dc.contributor.author | McNamara, MG | |
dc.contributor.author | Bridgewater, JA | |
dc.contributor.author | Lopes, A | |
dc.contributor.author | Wasan, H | |
dc.contributor.author | Malka, D | |
dc.contributor.author | Jensen, HR | |
dc.contributor.author | Okusaka, T | |
dc.contributor.author | Knox, JJ | |
dc.contributor.author | Wagner, AD | |
dc.contributor.author | Cunningham, D | |
dc.contributor.author | Shannon, J | |
dc.contributor.author | Goldstein, D | |
dc.contributor.author | Moehler, MH | |
dc.contributor.author | Bekaii-Saab, TS | |
dc.contributor.author | Valle, JW | |
dc.coverage.spatial | San Francisco, CA | |
dc.date.accessioned | 2017-05-26T15:32:36Z | |
dc.date.issued | 2016-02-01 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000378109600368&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (4), pp. ? - ? (1) | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/662 | |
dc.identifier.eissn | 1527-7755 | |
dc.identifier.doi | 10.1200/jco.2016.34.4_suppl.382 | |
dc.format.extent | ? - ? (1) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Oncology | |
dc.title | Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies. | |
dc.type | Other | |
rioxxterms.versionofrecord | 10.1200/jco.2016.34.4_suppl.382 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-02-01 | |
rioxxterms.type | Other | |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | |
pubs.finish-date | 2016-01-23 | |
pubs.issue | 4 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.start-date | 2016-01-21 | |
pubs.volume | 34 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Medicine (RMH Smith Cunningham) | en_US |
dc.contributor.icrauthor | Cunningham, David | |